AAPM has contracted with NCRP to provide each AAPM Member in good standing access and download privileges of electronically available NCRP reports, commentaries and statements. This report was prepared by the National Council on Radiation Protection and Measurements (NCRP). The Council strives to provide accurate, complete and useful information in its reports. However, neither the NCRP, the members of NCRP, other persons contributing to or assisting in the preparation of this report, nor any person acting on the behalf of any of these parties (a) makes any warranty or representation, express or implied, with respect to the accuracy, completeness or usefulness of the information contained in this report, or that the use of any information, method or process disclosed in this report may not infringe on privately owned rights; or (b) assumes any liability with respect to the use of, or for damages resulting from the use of, any information, method or process disclosed in this report.
 |
Report No. 135 - Liver Cancer Risk from Internally-Deposited Radionuclides (2001)  Price: $25 PDF (AAPM Members FREE) Category: Reports Report No. 135 (2001) updates the liver cancer risk of Thorotrast in humans. Thorotrast, a radiographic contrast medium containing naturally occurring radionuclides of thorium was widely used in the first half of the twentieth century. An increased incidence of liver cancer in this population of patients has been known for some time. Utilizing data on the liver cancer risk of Thorotrast and of low-LET radiations in animals, the liver cancer risk of low-LET radiation in humans is also estimated. Scientific Committee: Antone L. Brooks, Co-Chairman Glenn N. Taylor, Co-Chairman Steve Benjamin G. van Kaick Kurt Wegener Horst Wesch |
DISCLAIMER